Literature DB >> 34793255

Use of Dual-Energy X-Ray Absorptiometry to Assess Soft Tissue Composition in Breast Cancer Survivors With and Without Lymphedema.

Betty J Smoot1, Judy Mastick2, John Shepherd3, Steven M Paul2, Kord M Kober2, Bruce A Cooper2, Yvette P Conley4, Niharika Dixit1, Marilyn J Hammer5, Mei R Fu6, Gary Abrams1, Christine Miaskowski1,2.   

Abstract

Background: In patients with lymphedema (LE), in addition to hand dominance, between-group comparisons of interlimb soft tissue differences need to account for differences in whole-body adiposity, measured directly by dual energy X-ray absorptiometry (DXA) or indirectly by body mass index. No study has evaluated the effects of hand dominance and whole-body adiposity on limb composition in patients with LE. This study's purpose was to compare soft tissue composition of affected and unaffected limbs of women with breast cancer, who did and did not have LE, controlling for dominance and percent body fat. Methods and
Results: Whole-body DXA scans were acquired and included measures of percent body fat, upper limb total mass, upper limb fat mass, and upper limb fat-free mass. Participants were classified into one of three groups: women without LE; women with only subjective LE; and women with objective signs of LE at the time of assessment. Differences among the LE groups were evaluated using analysis of variance (ANOVA) and Chi-square analyses. Analysis of covariance (ANCOVA) was used to control for percent body fat and for the affected limb dominance. Compared to women without LE, women with objective signs of LE have greater total limb mass, fat mass, and fat-free mass in their affected limbs, independent of affected side dominance and percent body fat. In addition, the interlimb differences in total mass, fat mass, and fat-free mass were greater for the women with objective signs of LE, compared to the other two groups. Conclusions: DXA is useful in identifying soft tissue changes in patients with LE. Given that limb circumferences measure only changes in limb volume and that bioimpedance provides estimates of extracellular fluid, DXA has the advantage of being able to estimate the volumes of specific tissues in the limb.

Entities:  

Keywords:  body mass index; breast cancer; circumference; dual-energy X-ray absorptiometry; lymphedema

Mesh:

Year:  2021        PMID: 34793255      PMCID: PMC9422781          DOI: 10.1089/lrb.2021.0030

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.349


  33 in total

Review 1.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

2.  Tissue composition changes and secondary lymphedema.

Authors:  E S Dylke; L C Ward; J D Meerkin; L Nery; S L Kilbreath
Journal:  Lymphat Res Biol       Date:  2013-12       Impact factor: 2.589

Review 3.  The Use of Noninvasive Imaging Techniques in the Assessment of Secondary Lymphedema Tissue Changes as Part of Staging Lymphedema.

Authors:  An Tassenoy; Dorien De Strijcker; Nele Adriaenssens; Pierre Lievens
Journal:  Lymphat Res Biol       Date:  2016-09       Impact factor: 2.589

Review 4.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

Authors:  Tracey DiSipio; Sheree Rye; Beth Newman; Sandi Hayes
Journal:  Lancet Oncol       Date:  2013-03-27       Impact factor: 41.316

Review 5.  TGF-beta signaling and the fibrotic response.

Authors:  Andrew Leask; David J Abraham
Journal:  FASEB J       Date:  2004-05       Impact factor: 5.191

6.  Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume.

Authors:  Antoinette P Sander; Nicole M Hajer; Kristie Hemenway; Amy C Miller
Journal:  Phys Ther       Date:  2002-12

7.  Tissue stretch decreases soluble TGF-beta1 and type-1 procollagen in mouse subcutaneous connective tissue: evidence from ex vivo and in vivo models.

Authors:  Nicole A Bouffard; Kenneth R Cutroneo; Gary J Badger; Sheryl L White; Thomas R Buttolph; H Paul Ehrlich; Debbie Stevens-Tuttle; Helene M Langevin
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

8.  Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.

Authors:  Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann
Journal:  Breast       Date:  2017-10-06       Impact factor: 4.380

Review 9.  Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Phys Ther       Date:  2017-07-01

Review 10.  Histopathologic Features of Lymphedema: A Molecular Review.

Authors:  Claire Y Li; Raghu P Kataru; Babak J Mehrara
Journal:  Int J Mol Sci       Date:  2020-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.